All articles — 4016 total
HGTY reported Q1 2026 results on May 6 just as the stock was nursing a rough month — and the earnings beat landed into a market that had already seen heavy insider selling across the entire executive team. The revenue…
WULF heads into its Q1 results on May 8 with an uncomfortable contrast at its centre: the founders cashed out over $20 million in late April while the stock surged to multi-month highs, and short sellers — still…
DAVE just delivered a beat-and-raise quarter and still dropped 5% on the day. That gap between the fundamental story and the price reaction is the tension that defines this week's note. Q1 earnings landed after the…
BBAI enters its May 11 earnings call in an almost uniquely hostile positioning environment — short interest near 26% of free float, the lending pool fully exhausted, and cost to borrow accelerating sharply. Against…
Astera Labs entered this week as a stock that had already doubled in a month. It leaves the week with the Street rushing to catch up after a clean earnings beat sent shorts covering and analysts hiking targets en…
IREN Limited heads into its May 14 earnings print with a remarkable setup: the stock has surged 57% over the past month, yet nearly one-in-five shares of the float remain short. Short sellers are sitting on significant…
BTSG is navigating a rare alignment of forces: a strong Q1 earnings beat has triggered a wall of analyst upgrades, yet short sellers remain a meaningful presence, and options traders have swung decidedly more defensive…
PABU, the iShares Paris-Aligned Climate Optimized MSCI USA ETF, heads into the week on a quiet but positive footing — up 11% over the past month and with short positioning that remains negligible by any measure. The…
Kyndryl Holdings just delivered a quarter that split the tape — revenue came in ahead of estimates, the profit number didn't, and management compounded the miss with a below-consensus profit outlook and an announcement…
Sports Entertainment Gaming Global Corporation — a sub-$5 Nasdaq micro-cap in the casinos and gaming sector — finds itself at the centre of one of the more extreme short-interest stories of the past month, with…
Portillo's just delivered one of the sharper post-earnings drops in the casual dining space this season, and the Street responded swiftly with target cuts across the board. The catalyst is straightforward. Q1 EPS came…
Nu Holdings heads into its May 14 earnings release with options traders showing the most defensive positioning of the past year, even as short interest remains modest and the lending market stays wide open. The…
Rocket Lab Corporation reports Q1 2026 results tomorrow evening with short sellers at their most active in months — and a fresh cohort of bullish analysts raising targets into the print. Short interest has nearly…
GXO Logistics entered its Q1 results with the most defensive options positioning in months — and the beat cleared the bar, even if the weekly damage was already done. The options story was the defining feature of the…
Lucid Group enters the post-earnings period with shorts building steadily and its analyst base turning more cautious — a combination that keeps the stock under pressure at $6.25. The borrow market is as tight as it…
IonQ enters the post-earnings session on the back foot for short sellers. The quantum computing company delivered a Q1 print that beat on every line, then raised full-year guidance well above consensus — and shares are…
YOU enters the post-earnings window with momentum the stock hasn't seen in months. Shares closed at $58.77 on Tuesday, up 9.3% on the week and 14.4% over the past month. The company just reported Q1 2026 results on May…
Joby Aviation headed into Tuesday's Q1 earnings print with short sellers at their most aggressive in months — only to see the results land well ahead of expectations and send the stock surging, leaving bears…
INTA heads into the post-earnings session with a story split cleanly in two: a short base that built aggressively into results, and a set of analyst reactions that span the widest possible range on the Street. The…
Monte Rosa Therapeutics reports Q1 results on May 8 with short sellers sitting at their most aggressive in months — and the stock priced well below where the Street sees fair value. The short interest story here is the…
